Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Nov 26;11(11):CD011423.
doi: 10.1002/14651858.CD011423.pub2.

Autologous platelet concentrates for treating periodontal infrabony defects

Massimo Del Fabbro  1 , Lorena Karanxha, Saurav Panda, Cristina Bucchi, Jayakumar Nadathur Doraiswamy, Malaiappan Sankari, Surendar Ramamoorthi, Sheeja Varghese, Silvio Taschieri
Affiliations
Meta-Analysis

Autologous platelet concentrates for treating periodontal infrabony defects

Massimo Del Fabbro et al. Cochrane Database Syst Rev. .

Abstract

Background: Periodontal disease is a condition affecting tooth-supporting tissues (gingiva, alveolar bone, periodontal ligament, and cementum), with the potential of introducing severe adverse effects on oral health. It has a complex pathogenesis which involves the combination of specific micro-organisms and a predisposing host response. Infrabony defects are one of the morphological types of alveolar bone defects that can be observed during periodontitis. Recent approaches for the treatment of infrabony defects, combine advanced surgical techniques with platelet-derived growth factors. These are naturally synthesized polypeptides, acting as mediators for various cellular activities during wound healing. It is believed that the adjunctive use of autologous platelet concentrates to periodontal surgical procedures produces a better and more predictable outcome for the treatment of infrabony defects.

Objectives: To assess the effects of autologous platelet concentrates (APC) used as an adjunct to periodontal surgical therapies (open flap debridement (OFD), OFD combined with bone grafting (BG), guided tissue regeneration (GTR), OFD combined with enamel matrix derivative (EMD)) for the treatment of infrabony defects.

Search methods: Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 27 February 2018); the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 1) in the Cochrane Library (searched 27 February 2018); MEDLINE Ovid (1946 to 27 February 2018); Embase Ovid (1980 to 27 February 2018); and LILACS BIREME Virtual Health Library (from 1982 to 27 February 2018). The US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials on 27 February 2018. No restrictions were placed on the language or date of publication when searching the electronic databases.

Selection criteria: We included randomised controlled trials (RCTs) of both parallel and split-mouth design, involving patients with infrabony defects requiring surgical treatment. Studies had to compare treatment outcomes of a specific surgical technique combined with APC, with the same technique when used alone.

Data collection and analysis: Two review authors independently conducted data extraction and risk of bias assessment, and analysed data following Cochrane methods. The primary outcomes assessed were: change in probing pocket depth (PD), change in clinical attachment level (CAL), and change in radiographic bone defect filling (RBF). We organised all data in four groups, each comparing a specific surgical technique when applied with the adjunct of APC or alone: 1. APC + OFD versus OFD, 2. APC + OFD + BG versus OFD + BG, 3. APC + GTR versus GTR, and 4. APC + EMD versus EMD.

Main results: We included 38 RCTs. Twenty-two had a split-mouth design, and 16 had a parallel design. The overall evaluated data included 1402 defects. Two studies were at unclear overall risk of bias, while the remaining 36 studies had a high overall risk of bias.1. APC + OFD versus OFD alone Twelve studies were included in this comparison, with a total of 510 infrabony defects. There is evidence of an advantage in using APC globally from split-mouth and parallel studies for all three primary outcomes: PD (mean difference (MD) 1.29 mm, 95% confidence interval (CI) 1.00 to 1.58 mm; P < 0.001; 12 studies; 510 defects; very low-quality evidence); CAL (MD 1.47 mm, 95% CI 1.11 to 1.82 mm; P < 0.001; 12 studies; 510 defects; very low-quality evidence); and RBF (MD 34.26%, 95% CI 30.07% to 38.46%; P < 0.001; 9 studies; 401 defects; very low-quality evidence).2. APC + OFD + BG versus OFD + BG Seventeen studies were included in this comparison, with a total of 569 infrabony defects. Considering all follow-ups, as well as 3 to 6 months and 9 to 12 months, there is evidence of an advantage in using APC from both split-mouth and parallel studies for all three primary outcomes: PD (MD 0.54 mm, 95% CI 0.33 to 0.75 mm; P < 0.001; 17 studies; 569 defects; very low-quality evidence); CAL (MD 0.72 mm, 95% CI 0.43 to 1.00 mm; P < 0.001; 17 studies; 569 defects; very low-quality evidence); and RBF (MD 8.10%, 95% CI 5.26% to 10.94%; P < 0.001; 11 studies; 420 defects; very low-quality evidence).3. APC + GTR versus GTR alone Seven studies were included in this comparison, with a total of 248 infrabony defects. Considering all follow-ups, there is probably a benefit for APC for both PD (MD 0.92 mm, 95% CI -0.02 to 1.86 mm; P = 0.05; very low-quality evidence) and CAL (MD 0.42 mm, 95% CI -0.02 to 0.86 mm; P = 0.06; very low-quality evidence). However, given the wide confidence intervals, there might be a possibility of a slight benefit for the control. When considering a 3 to 6 months and a 9 to 12 months follow-up there were no benefits evidenced, except for CAL at 3 to 6 months (MD 0.54 mm, 95% CI 0.18 to 0.89 mm; P = 0.003; 3 studies; 134 defects). No RBF data were available.4. APC + EMD versus EMDTwo studies were included in this comparison, with a total of 75 infrabony defects. There is insufficient evidence of an overall advantage of using APC for all three primary outcomes: PD (MD 0.13 mm, 95% CI -0.05 to 0.30 mm; P = 0.16; 2 studies; 75 defects; very low-quality evidence), CAL (MD 0.10 mm, 95% CI -0.13 to 0.32 mm; P = 0.40; 2 studies; 75 defects; very low-quality evidence), and RBF (MD -0.60%, 95% CI -6.21% to 5.01%; P = 0.83; 1 study; 49 defects; very low-quality evidence).All studies in all groups reported a survival rate of 100% for the treated teeth. No complete pocket closure was reported. No quantitative analysis regarding patients' quality of life was possible.

Authors' conclusions: There is very low-quality evidence that the adjunct of APC to OFD or OFD + BG when treating infrabony defects may improve probing pocket depth, clinical attachment level, and radiographic bone defect filling. For GTR or EMD, insufficient evidence of an advantage in using APC was observed.

PubMed Disclaimer

Conflict of interest statement

The review authors declare they have no conflicts of interest.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Forest plot of comparison: 1 APC + OFD versus OFD (9‐12 months follow‐up); outcome: 1.1 Probing depth (mm).
5
5
Forest plot of comparison: 2 APC + OFD + BG versus OFD + BG (all follow‐ups); outcome: 2.1 Probing depth (mm).
6
6
Forest plot of comparison: 5 APC + GTR versus GTR (all follow‐ups), outcome: 5.1 Probing depth (mm).
1.1
1.1. Analysis
Comparison 1 APC + OFD versus OFD (9‐12 months), Outcome 1 Probing depth (mm).
1.2
1.2. Analysis
Comparison 1 APC + OFD versus OFD (9‐12 months), Outcome 2 Clinical attachment level (mm).
1.3
1.3. Analysis
Comparison 1 APC + OFD versus OFD (9‐12 months), Outcome 3 Radiographic bone defect filling (%).
2.1
2.1. Analysis
Comparison 2 APC + OFD + BG versus OFD + BG (all follow‐ups), Outcome 1 Probing depth (mm).
2.2
2.2. Analysis
Comparison 2 APC + OFD + BG versus OFD + BG (all follow‐ups), Outcome 2 Clinical attachment level (mm).
2.3
2.3. Analysis
Comparison 2 APC + OFD + BG versus OFD + BG (all follow‐ups), Outcome 3 Radiographic bone defect filling (%).
3.1
3.1. Analysis
Comparison 3 APC + OFD + BG versus OFD + BG (3‐6 months), Outcome 1 Probing depth (mm).
3.2
3.2. Analysis
Comparison 3 APC + OFD + BG versus OFD + BG (3‐6 months), Outcome 2 Clinical attachment level (mm).
3.3
3.3. Analysis
Comparison 3 APC + OFD + BG versus OFD + BG (3‐6 months), Outcome 3 Radiographic bone defect filling (%).
4.1
4.1. Analysis
Comparison 4 APC + OFD + BG versus OFD + BG (9‐12 months), Outcome 1 Probing depth (mm).
4.2
4.2. Analysis
Comparison 4 APC + OFD + BG versus OFD + BG (9‐12 months), Outcome 2 Clinical attachment level (mm).
4.3
4.3. Analysis
Comparison 4 APC + OFD + BG versus OFD + BG (9‐12 months), Outcome 3 Radiographic bone defect filling (%).
5.1
5.1. Analysis
Comparison 5 APC + GTR versus GTR (all follow‐ups), Outcome 1 Probing depth (mm).
5.2
5.2. Analysis
Comparison 5 APC + GTR versus GTR (all follow‐ups), Outcome 2 Clinical attachment level (mm).
6.1
6.1. Analysis
Comparison 6 APC + GTR versus GTR (3‐6 months), Outcome 1 Probing depth (mm).
6.2
6.2. Analysis
Comparison 6 APC + GTR versus GTR (3‐6 months), Outcome 2 Clinical attachment level (mm).
7.1
7.1. Analysis
Comparison 7 APC + GTR versus GTR (9‐12 months), Outcome 1 Probing depth (mm).
7.2
7.2. Analysis
Comparison 7 APC + GTR versus GTR (9‐12 months), Outcome 2 Clinical attachment level (mm).
8.1
8.1. Analysis
Comparison 8 APC + EMD versus EMD (all follow‐ups), Outcome 1 Probing depth (mm).
8.2
8.2. Analysis
Comparison 8 APC + EMD versus EMD (all follow‐ups), Outcome 2 Clinical attachment level (mm).
8.3
8.3. Analysis
Comparison 8 APC + EMD versus EMD (all follow‐ups), Outcome 3 Radiographic bone defect filling (%).
See this image and copyright information in PMC

Comment in

References

References to studies included in this review

Agarwal 2014 {published data only}
    1. Agarwal A, Gupta ND. Platelet‐rich plasma combined with decalcified freeze‐dried bone allograft for the treatment of noncontained human intrabony periodontal defects: a randomized controlled split‐mouth study. International Journal of Periodontics and Restorative Dentistry 2014;34(5):705‐11. - PubMed
Agarwal 2015 {published data only}
    1. Agarwal A, Gupta ND, Jain A. Platelet rich fibrin combined with decalcified freeze‐dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split‐mouth clinical trail. Acta Odontologica Scandinavica 2016;74(1):36‐43. - PubMed
Agarwal 2016 {published data only}
    1. Agarwal P, Chatterjee A, Gokhale S, Singh HP, Kandwal A. Evaluation of platelet‐rich plasma alone or in combination with demineralized freeze dried bone allograft in treatment of periodontal infrabony defects: a comparative clinical trial. Journal of Indian Society of Periodontology 2016;20(1):42‐7. - PMC - PubMed
Arabaci 2017 {published data only}
    1. Arabaci T, Kose O, Albayrak M, Cicek Y, Kizildag A. Advantages of autologous platelet‐rich fibrin membrane on gingival crevicular fluid growth factor levels and periodontal healing: a randomized split‐mouth clinical study. Journal of Periodontology 2017;88(8):771‐7. [DOI: 10.1902/jop.2017.160485] - DOI - PubMed
Aydemir 2016 {published data only}
    1. Aydemir Turkal H, Demirer S, Dolgun A, Keceli HG. Evaluation of the adjunctive effect of platelet‐rich fibrin to enamel matrix derivative in the treatment of intrabony defects. Six‐month results of a randomized, split‐mouth, controlled clinical study. Journal of Clinical Periodontology 2016;43(11):955‐64. [DOI: 10.1111/jcpe.12598] - DOI - PubMed
Camargo 2009 {published data only}
    1. Camargo PM, Lekovic V, Weinlaender M, Divnic‐Resnik T, Pavlovic M, Kenney EB. A surgical reentry study on the influence of platelet‐rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans. Journal of Periodontology 2009;80(6):915‐23. - PubMed
Chandradas 2016 {published data only}
    1. Chandradas ND, Ravindra S, Rangaraju VM, Jain S, Dasappa S. Efficacy of platelet rich fibrin in the treatment of human intrabony defects with or without bone graft: a randomized controlled trial. Journal of International Society of Preventive & Community Dentistry 2016;6(Suppl 2):S153‐9. - PMC - PubMed
Christgau 2006 {published data only}
    1. Christgau M, Moder D, Wagner J, Glässl M, Hiller KA, Wenzel A, et al. Influence of autologous platelet concentrate on healing in intrabony defects following guided tissue regeneration therapy: a randomized prospective clinical split‐mouth study. Journal of Clinical Periodontology 2006;33(12):908‐21. - PubMed
Demir 2007 {published data only}
    1. Demir B, Sengün D, Berberoğlu A. Clinical evaluation of platelet‐rich plasma and bioactive glass in the treatment of intrabony defects. Journal of Clinical Periodontology 2007;34(8):709‐15. - PubMed
Döri 2007a {published data only}
    1. Döri F, Huszár T, Nikolidakis D, Arweiler NB, Gera I, Sculean A. Effect of platelet‐rich plasma on the healing of intrabony defects treated with a natural bone mineral and a collagen membrane. Journal of Clinical Periodontology 2007;34(3):254‐61. - PubMed
Döri 2007b {published data only}
    1. Döri F, Huszár T, Nikolidakis D, Arweiler NB, Gera I, Sculean A. Effect of platelet‐rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes. Journal of Periodontology 2007;78(6):983‐90. - PubMed
Döri 2008a {published data only}
    1. Döri F, Huszár T, Nikolidakis D, Tihanyi D, Horváth A, Arweiler NB, et al. Effect of platelet‐rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes. Journal of Periodontology 2008;79(4):660‐9. - PubMed
Döri 2008b {published data only}
    1. Döri F, Nikolidakis D, Húszár T, Arweiler NB, Gera I, Sculean A. Effect of platelet‐rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral. Journal of Clinical Periodontology 2008;35(1):44‐50. - PubMed
Döri 2009 {published data only}
    1. Döri F, Kovács V, Arweiler NB, Huszár T, Gera I, Nikolidakis D, et al. Effect of platelet‐rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study. Journal of Periodontology 2009;80(10):1599‐605. - PubMed
Elgendy 2015 {published data only}
    1. Elgendy EA, Abo Shady TE. Clinical and radiographic evaluation of nanocrystalline hydroxyapatite with or without platelet‐rich fibrin membrane in the treatment of periodontal intrabony defects. Journal of Indian Society of Periodontology 2015;19(1):61‐5. - PMC - PubMed
Garg 2017 {published data only}
    1. Garg K, Srivastava R, Verma PK, Gautam A, Tripathi V, Agarwal S. Clinical evaluation of platelet rich plasma when combined with an alloplastic bone graft material in the treatment of intrabony periodontal defects. Saudi Journal of Oral Sciences 2017;4(1):33‐40.
Gupta 2014 {published data only}
    1. Gupta G. Clinical and radiographic evaluation of intrabony defects in localized aggressive periodontitis patients with platelet rich plasma/hydroxyapatite graft: a comparative controlled clinical trial. Contemporary Clinical Dentistry 2014;5(4):445‐51. - PMC - PubMed
Hanna 2004 {published data only}
    1. Hanna R, Trejo PM, Weltman RL. Treatment of intrabony defects with bovine‐derived xenograft alone and in combination with platelet‐rich plasma: a randomized clinical trial. Journal of Periodontology 2004;75(12):1668‐77. - PubMed
Hassan 2012 {published data only}
    1. Hassan KS, Alagl AS, Abdel‐Hady A. Torus mandibularis bone chips combined with platelet rich plasma gel for treatment of intrabony osseous defects: clinical and radiographic evaluation. International Journal of Oral and Maxillofacial Surgery 2012;41(12):1519‐26. - PubMed
Kanoriya 2016 {published data only}
    1. Kanoriya D, Pradeep AR, Singhal S, Garg V, Guruprasad CN. Synergistic approach using platelet‐rich fibrin and 1% alendronate for intrabony defect treatment in chronic periodontitis: a randomized clinical trial. Journal of Periodontology 2016;87(12):1427‐35. - PubMed
Kaushick 2011 {published data only}
    1. Kaushick BT, Jayakumar ND, Padmalatha O, Varghese S. Treatment of human periodontal infrabony defects with hydroxyapatite + β tricalcium phosphate bone graft alone and in combination with platelet rich plasma: a randomized clinical trial. Indian Journal of Dental Research 2011;22(4):505‐10. - PubMed
Khosropanah 2015 {published data only}
    1. Khosropanah H, Shahidi S, Basri A, Houshyar M. Treatment of intrabony defects by DFDBA alone or in combination with PRP: a split‐mouth randomized clinical and three‐dimensional radiographic trial. Journal of Dentistry (Tehran, Iran) 2015;12(10):764‐73. - PMC - PubMed
Martande 2016 {published data only}
    1. Martande SS, Kumari M, Pradeep AR, Singh SP, Suke DK, Guruprasad CN. Platelet‐rich fibrin combined with 1.2% atorvastatin for treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2016;87(9):1039‐46. - PubMed
Naqvi 2017 {published data only}
    1. Naqvi A, Gopalakrishnan D, Bhasin MT, Sharma N, Haider K, Martande S. Comparative evaluation of bioactive glass putty and platelet rich fibrin in the treatment of human periodontal intrabony defects: a randomized control trial. Journal of Clinical and Diagnostic Research 2017;11(7):ZC09‐ZC13. - PMC - PubMed
Okuda 2005 {published data only}
    1. Okuda K, Tai H, Tanabe K, Suzuki H, Sato T, Kawase T, et al. Platelet‐rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. Journal of Periodontology 2005;76(6):890‐8. - PubMed
Ozdemir 2012 {published data only}
    1. Ozdemir B, Okte E. Treatment of intrabony defects with beta‐tricalciumphosphate alone and in combination with platelet‐rich plasma. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 2012;100(4):976‐83. - PubMed
Panda 2016 {published data only}
    1. Panda S, Sankari M, Satpathy A, Jayakumar D, Mozzati M, Mortellaro C, et al. Adjunctive effect of autologus platelet‐rich fibrin to barrier membrane in the treatment of periodontal intrabony defects. Journal of Craniofacial Surgery 2016;27(3):691‐6. - PubMed
Patel 2017 {published data only}
    1. Patel GK, Gaekwad SS, Gujjari SK, Kumar V. Platelet‐rich fibrin in regeneration of intrabony defects: a randomized controlled trial. Journal of Periodontology 2017;88(11):1192‐9. - PubMed
Piemontese 2008 {published data only}
    1. Piemontese M, Aspriello SD, Rubini C, Ferrante L, Procaccini M. Treatment of periodontal intrabony defects with demineralized freeze‐dried bone allograft in combination with platelet‐rich plasma: a comparative clinical trial. Journal of Periodontology 2008;79(5):802‐10. - PubMed
Pradeep 2015 {published data only}
    1. Pradeep AR, Nagpal K, Karvekar S, Patnaik K, Naik SB, Guruprasad CN. Platelet rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2015;86(6):729‐37. - PubMed
Pradeep 2016 {published data only}
    1. Pradeep AR, Garg V, Kanoriya D, Singhal S. Platelet‐rich fibrin with 1.2% rosuvastatin for treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2016;87(12):1468‐73. - PubMed
Ravi 2017 {published data only}
    1. Ravi S, Malaiappan S, Varghese S, Jayakumar ND, Prakasam G. Additive effect of plasma rich in growth factors with guided tissue regeneration in treatment of intrabony defects in patients with chronic periodontitis: a split‐mouth randomized controlled clinical trial. Journal of Periodontology 2017;88(9):839‐45. - PubMed
Rosamma Joseph 2012 {published data only}
    1. Rosamma Joseph V, Raghunath A, Sharma N. Clinical effectiveness of autologous platelet rich fibrin in the management of infrabony periodontal defects. Singapore Dental Journal 2012;33(1):5‐12. - PubMed
Sezgin 2017 {published data only}
    1. Sezgin Y, Uraz A, Taner IL, Çulhaoğlu R. Effects of platelet‐rich fibrin on healing of intra‐bony defects treated with anorganic bovine bone mineral. Brazilian Oral Research 2017;31:e15. - PubMed
Sharma 2011 {published data only}
    1. Sharma A, Pradeep AR. Treatment of 3‐wall intrabony defects in patients with chronic periodontitis with autologous platelet‐rich fibrin: a randomized controlled clinical trial. Journal of Periodontology 2011;82(12):1705‐12. - PubMed
Shukla 2016 {published data only}
    1. Shukla S, Chug A, Mahesh L, Grover HS. Effect of addition of platelet‐rich plasma to calcium phosphosilicate on healing at 9 months in periodontal intrabony defects. Journal of Contemporary Dental Practice 2016;17(3):230‐4. - PubMed
Thorat 2011 {published data only}
    1. Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet‐rich fibrin in the treatment of intrabony defects: a controlled clinical trial. Journal of Clinical Periodontology 2011;38(10):925‐32. - PubMed
Thorat 2017 {published data only}
    1. Thorat M, Baghele ON, S RP. Adjunctive effect of autologous platelet‐rich fibrin in the treatment of intrabony defects in localized aggressive periodontitis patients: a randomized controlled split‐mouth clinical trial. International Journal of Periodontics & Restorative Dentistry 2017;37(6):e302‐9. - PubMed

References to studies excluded from this review

Agarwal 2017 {published data only}
    1. Agarwal I, Chandran S, Nadig P. Comparative evaluation of the efficacy of platelet‐rich fibrin and calcium phosphosilicate putty alone and in combination in the treatment of intrabony defects: a randomized clinical and radiographic study. Contemporary Clinical Dentistry 2017;8(2):205‐10. - PMC - PubMed
Aleksić 2008 {published data only}
    1. Aleksić Z, Janković S, Dimitrijević B, Pucar A, Lazić V, Leković V. Clinical impact of platelet rich plasma in treatment of gingival recessions [Primena plazme bogate trombocitima urekonstruktivnoj mukogingivnoj hirurgiji]. Srpski Arhiv za Celokupno Lekarstvo 2008;136(3‐4):95‐103. - PubMed
Aroca 2009 {published data only}
    1. Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet‐rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6‐month study. Journal of Periodontology 2009;80(2):244‐52. - PubMed
Bajaj 2017 {published data only}
    1. Bajaj P, Agarwal E, Rao NS, Naik SB, Pradeep AR, Kalra N, et al. Autologous platelet‐rich fibrin in the treatment of 3‐wall intrabony defects in aggressive periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2017;88(11):1186‐91. - PubMed
Camargo 2002 {published data only}
    1. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet‐rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. Journal of Periodontal Research 2002;37(4):300‐6. - PubMed
Camargo 2005 {published data only}
    1. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. A reentry study on the use of bovine porous bone mineral, GTR, and platelet‐rich plasma in the regenerative treatment of intrabony defects in humans. International Journal of Periodontics and Restorative Dentistry 2005;25(1):49‐59. - PubMed
Cetinkaya 2014 {published data only}
    1. Cetinkaya BO, Keles GC, Pamuk F, Balli U, Keles ZP. Long‐term clinical results on the use of platelet concentrate in the treatment of intrabony periodontal defects. Acta Odontologica Scandinavica 2014;72(2):92‐8. - PubMed
Chatterjee 2017 {published data only}
    1. Chatterjee A, Pradeep AR, Garg V, Yajamanya S, Ali MM, Priya VS. Treatment of periodontal intrabony defects using autologous platelet‐rich fibrin and titanium platelet‐rich fibrin: a randomized, clinical, comparative study. Journal of Investigative and Clinical Dentistry 2017;8(3):e12231. - PubMed
Cheung 2004 {published data only}
    1. Cheung WS, Griffin TJ. A comparative study of root coverage with connective tissue and platelet concentrate grafts: 8‐month results. Journal of Periodontology 2004;75(12):1678‐87. - PubMed
Cieplik 2018 {published data only}
    1. Cieplik F, Tabenski L, Hiller KA, Schmalz G, Buchalla W, Christgau M. Influence of autogenous platelet concentrate on combined GTR/graft therapy in intrabony defects: a 13‐year follow‐up of a randomized controlled clinical split‐mouth study. Journal of Clinical Periodontology 2018;45(1):382‐91. - PubMed
Cortellini 1995 {published data only}
    1. Cortellini P, Pini Prato GP, Tonetti MS. No detrimental effect of fibrin glue on the regeneration of intrabony defects. A controlled clinical trial. Journal of Clinical Periodontology 1995;22(9):697‐702. - PubMed
Dogan 2015 {published data only}
    1. Bozkurt Dogan S, Ongoz Dede F, Balli U, Atalay EN, Durmuslar MC. Concentrated growth factor in the treatment of adjacent multiple gingival recessions: a split‐mouth randomized clinical trial. Journal of Clinical Periodontology 2015;42(9):868‐75. - PubMed
Döri 2013 {published data only}
    1. Döri F, Arweiler N, Húszár T, Gera I, Miron RJ, Sculean A. Five‐year results evaluating the effects of platelet‐rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral. Journal of Periodontology 2013;84(11):1546‐55. - PubMed
Eren 2014 {published data only}
    1. Eren G, Atilla G. Platelet‐rich fibrin in the treatment of localized gingival recessions: a split‐mouth randomized clinical trial. Clinical Oral Investigations 2014;18(8):1941‐8. - PubMed
Gupta 2014b {published data only}
    1. Gupta SJ, Jhingran R, Gupta V, Bains VK, Madan R, Rizvi I. Efficacy of platelet‐rich fibrin vs. enamel matrix derivative in the treatment of periodontal intrabony defects: a clinical and cone beam computed tomography study. Journal of the International Academy of Periodontology 2014;16(3):86‐96. - PubMed
Harnack 2009 {published data only}
    1. Harnack L, Boedeker RH, Kurtulus I, Boehm S, Gonzales J, Meyle J. Use of platelet‐rich plasma in periodontal surgery ‐ a prospective randomised double blind clinical trial. Clinical Oral Investigations 2009;13(2):179‐87. - PubMed
Huang 2005 {published data only}
    1. Huang LH, Neiva RE, Soehren SE, Giannobile WV, Wang HL. The effect of platelet‐rich plasma on the coronally advanced flap root coverage procedure: a pilot human trial. Journal of Periodontology 2005;76(10):1768‐77. - PubMed
Jankovic 2010 {published data only}
    1. Jankovic S, Aleksic Z, Milinkovic I, Dimitrijevic B. The coronally advanced flap in combination with platelet‐rich fibrin (PRF) and enamel matrix derivative in the treatment of gingival recession: a comparative study. European Journal of Esthetic Dentistry 2010;5(3):260‐73. - PubMed
Jankovic 2012 {published data only}
    1. Jankovic S, Aleksic Z, Klokkevold P, Lekovic V, Dimitrijevic B, Kenney EB, et al. Use of platelet‐rich fibrin membrane following treatment of gingival recession: a randomized clinical trial. International Journal of Periodontics & Restorative Dentistry 2012;32(2):e41‐50. - PubMed
Jovicić 2013 {published data only}
    1. Jovicić B, Lazić Z, Nedić M, Matijević S, Gostović‐Spadijer A. Therapeutic efficacy of connective tissue autotransplants with periosteum and platelet rich plasma in the menagement of gingival recession. Vojnosanitetski Pregled 2013;70(7):664‐9. - PubMed
Keceli 2008 {published data only}
    1. Keceli HG, Sengun D, Berberoğlu A, Karabulut E. Use of platelet gel with connective tissue grafts for root coverage: a randomized controlled trial. Journal of Clinical Periodontology 2008;35(3):255‐62. - PubMed
Keles 2006 {published data only}
    1. Keles GC, Cetinkaya BO, Albayrak D, Koprulu H, Acikgoz G. Comparison of platelet pellet and bioactive glass in periodontal regenerative therapy. Acta Odontologica Scandinavica 2006;64(6):327‐33. - PubMed
Lekovic 2012 {published data only}
    1. Lekovic V, Milinkovic I, Aleksic Z, Jankovic S, Stankovic P, Kenney EB, et al. Platelet‐rich fibrin and bovine porous bone mineral vs platelet‐rich fibrin in the treatment of intrabony periodontal defects. Journal of Periodontal Research 2012;47(4):409‐17. - PubMed
Menezes 2012 {published data only}
    1. Menezes LM, Rao J. Long‐term clinical evaluation of platelet‐rich plasma in the treatment of human periodontal intraosseous defects: a comparative clinical trial. Quintessence International 2012;43(7):571‐82. - PubMed
Moder 2012 {published data only}
    1. Moder D, Taubenhansl F, Hiller KA, Schmalz G, Christgau M. Influence of autogenous platelet concentrate on combined GTR/graft therapy in intrabony defects: a 7‐year follow‐up of a randomized prospective clinical split‐mouth study. Journal of Clinical Periodontology 2012;39(5):457‐65. - PubMed
Ouyang 2006 {published data only}
    1. Ouyang XY, Qiao J. Effect of platelet‐rich plasma in the treatment of periodontal intrabony defects in humans. Chinese Medical Journal 2006;119(18):1511‐21. - PubMed
Padma 2013 {published data only}
    1. Padma R, Shilpa A, Kumar PA, Nagasri M, Kumar C, Sreedhar A. A split‐mouth randomized controlled study to evaluate the adjunctive effect of platelet‐rich fibrin to coronally advanced flap in Miller's class‐I and II recession defects. Journal of Indian Society of Periodontology 2013;17(5):631‐6. - PMC - PubMed
Pradeep 2012a {published data only}
    1. Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB. Comparative evaluation of autologous platelet‐rich fibrin and platelet‐rich plasma in the treatment of 3‐wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2012;83(12):1499‐507. - PubMed
Pradeep 2017 {published data only}
    1. Pradeep AR, Bajaj P, Rao NS, Agarwal E, Naik SB. Platelet‐rich fibrin combined with a porous hydroxyapatite graft for the treatment of 3‐wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. Journal of Periodontology 2017;88(12):1288‐96. - PubMed
Qiao 2016 {published data only}
    1. Qiao J, Duan J, Zhang Y, Chu Y, Sun C. The effect of concentrated growth factors in the treatment of periodontal intrabony defects. Future Science OA 2016;2(4):FS136. [DOI: 10.4155/fsoa-2016-0019.] - DOI - PMC - PubMed
Saini 2011 {published data only}
    1. Saini N, Sikri P, Gupta H. Evaluation of the relative efficacy of autologous platelet‐rich plasma in combination with β‐tricalcium phosphate alloplast versus an alloplast alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian Journal of Dental Research 2011;22(1):107‐15. - PubMed
Shah 2015 {published data only}
    1. Shah M, Patel J, Dave D, Shah S. Comparative evaluation of platelet‐rich fibrin with demineralized freeze‐dried bone allograft in periodontal infrabony defects: a randomized controlled clinical study. Journal of Indian Society of Periodontology 2015;19(1):56‐60. - PMC - PubMed
Shepherd 2009 {published data only}
    1. Shepherd N, Greenwell H, Hill M, Vidal R, Scheetz JP. Root coverage using acellular dermal matrix and comparing a coronally positioned tunnel with and without platelet‐rich plasma: a pilot study in humans. Journal of Periodontology 2009;80(3):397‐404. - PubMed
Shivakumar 2016 {published data only}
    1. Shivakumar MA, Gopal SV, Govindaraju P, Ramayya S, Bennadi D, Mruthyuenjaya RK. Evaluation of treatment for isolated bilateral Miller's class I or II gingival recession with platelet rich fibrin membrane ‐ a comparative study. Journal of Young Pharmacists 2016;8(3):206‐13.
Thamaraiselvan 2015 {published data only}
    1. Thamaraiselvan M, Elavarasu S, Thangakumaran S, Gadagi JS, Arthie T. Comparative clinical evaluation of coronally advanced flap with or without platelet rich fibrin membrane in the treatment of isolated gingival recession. Journal of Indian Society of Periodontology 2015;19(1):66‐71. - PMC - PubMed
Trombelli 1995 {published data only}
    1. Trombelli L, Schincaglia GP, Zangari F, Griselli A, Scabbia A, Calura G. Effects of tetracycline HCl conditioning and fibrin‐fibronectin system application in the treatment of buccal gingival recession with guided tissue regeneration. Journal of Periodontology 1995;66(5):313‐20. - PubMed
Trombelli 1996 {published data only}
    1. Trombelli L, Scabbia A, Wikesjö UM, Calura G. Fibrin glue application in conjunction with tetracycline root conditioning and coronally positioned flap procedure in the treatment of human gingival recession defects. Journal of Clinical Periodontology 1996;23(9):861‐7. - PubMed
Yajamanya 2017 {published data only}
    1. Yajamanya SR, Chatterjee A, Hussain A, Coutinho A, Das S, Subbaiah S. Bioactive glass versus autologous platelet‐rich fibrin for treating periodontal intrabony defects: Aa comparative clinical study. Journal of Indian Society of Periodontology 2017;21(1):32‐6. - PMC - PubMed
Yassibag‐Berkman 2007 {published data only}
    1. Yassibag‐Berkman Z, Tuncer O, Subasioglu T, Kantarci A. Combined use of platelet‐rich plasma and bone grafting with or without guided tissue regeneration in the treatment of anterior interproximal defects. Journal of Periodontology 2007;78(5):801‐9. - PubMed
Yen 2007 {published data only}
    1. Yen CA, Griffin TJ, Cheung WS, Chen J. Effects of platelet concentrate on palatal wound healing after connective tissue graft harvesting. Journal of Periodontology 2007;78(4):601‐10. - PubMed

Additional references

AAP 1992
    1. AAP. Glossary of Periodontal Terms. 3rd Edition. Chicago (IL): American Academy of Periodontology, 1992.
Anitua 2001
    1. Anitua E. The use of plasma‐rich growth factors (PRGF) in oral surgery. Practical Procedures and Aesthetic Dentistry 2001;13(6):487‐93. - PubMed
Caffesse 1986
    1. Caffesse RG, Sweeney PL, Smith BA. Scaling and root planing with and without periodontal flap surgery. Journal of Clinical Periodontology 1986;13(3):205‐10. [PUBMED: 3517073] - PubMed
Carroll 2005
    1. Carroll RJ, Amoczky SP, Graham S, O'Connell SM. Characterization of Autologous Growth Factors in Cascade Platelet Rich Fibrin Matrix (PRFM). Edison (NJ): Musculoskeletal Transplant Foundation, 2005.
Castro 2017
    1. Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, et al. Regenerative potential of leucocyte‐ and platelet‐rich fibrin. Part A: intrabony defects, furcation defects and periodontal plastic surgery. A systematic review and meta‐analysis. Journal of Clinical Periodontology 2017;44(1):67‐82. - PMC - PubMed
Choukroun 2001
    1. Choukroun J, Adda F, Schoeffler C, Vervelle A. An opportunity in perio‐implantology: the PRF [Une opportunité en paro‐implantologie: le PRF]. Implantodontie 2001;42:55‐62.
Cochran 2003
    1. Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. Journal of Periodontology 2003;74(9):1269‐81. [PUBMED: 14584859] - PubMed
Cortellini 1996
    1. Cortellini P, Pini Prato G, Tonetti MS. Periodontal regeneration of human intrabony defects with bioresorbable membranes. A controlled clinical trial. Journal of Periodontology 1996;67(3):217‐23. [PUBMED: 8708952] - PubMed
Crea 2014
    1. Crea A, Deli G, Littarru C, Lajolo C, Orgeas GV, Tatakis DN. Intrabony defects, open‐flap debridement, and decortication: a randomized clinical trial. Journal of Periodontology 2014;85(1):34‐42. [PUBMED: 23537123] - PubMed
Del Fabbro 2011
    1. Fabbro M, Bortolin M, Taschieri S, Weinstein R. Is platelet concentrate advantageous for the surgical treatment of periodontal diseases? A systematic review and meta‐analysis. Journal of Periodontology 2011;82(8):1100‐11. - PubMed
Del Fabbro 2013
    1. Fabbro M, Ceci C, Taschieri S. Systematic review on the effect of platelet concentrates for the surgical treatment of periodontal defects [Revisione sistematica della letteratura sull'effetto dei concentrati piastrinici nel trattamento chirurgico dei difetti parodontali]. Dental Cadmos 2013;81(3):138‐45.
Dohan Ehrenfest 2009
    1. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet‐rich plasma (P‐PRP) to leucocyte‐ and platelet‐rich fibrin (L‐PRF). Trends in Biotechnology 2009;27(3):158‐67. - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9. - PubMed
Esposito 2009
    1. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD003875.pub3] - DOI - PMC - PubMed
Follmann 1992
    1. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45(7):769‐73. - PubMed
Giannobile 1996
    1. Giannobile WV. The potential role of growth and differentiation factors in periodontal regeneration. Journal of Periodontology 1996;67(5):545‐53. [PUBMED: 8724716] - PubMed
GRADEpro GDT 2015 [Computer program]
    1. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 27 August 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hoidal 2008
    1. Hoidal MJ, Grimard BA, Mills MP, Schoolfield JD, Mellonig JT, Mealey BL. Clinical evaluation of demineralized freeze‐dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans. Journal of Periodontology 2008;79(12):2273‐80. [PUBMED: 19053917] - PubMed
Kinane 2001
    1. Kinane DF. Causation and pathogenesis of periodontal disease. Periodontology 2000 2001;25:8‐20. - PubMed
Kotsovilis 2010
    1. Kotsovilis S, Markou N, Pepelassi E, Nikolidakis D. The adjunctive use of platelet‐rich plasma in the therapy of periodontal intraosseous defects: a systematic review. Journal of Periodontal Research 2010;45(3):428‐43. - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Marx 1998
    1. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet‐rich plasma: growth factor enhancement for bone grafts. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 1998;85(6):638‐46. - PubMed
Needleman 2006
    1. Needleman I, Worthington HV, Giedrys‐Leeper E, Tucker R. Guided tissue regeneration for periodontal infra‐bony defects. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001724.pub2] - DOI - PubMed
Papapanou 1991
    1. Papapanou PN, Wennström JL. The angular bony defect as indicator of further alveolar bone loss. Journal of Clinical Periodontology 1991;18(5):317‐22. [PUBMED: 2066446 ] - PubMed
Pihlstrom 2005
    1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366(9499):1809‐20. [PUBMED: 16298220] - PubMed
Plachokova 2008
    1. Plachokova AS, Nikolidakis D, Mulder J, Jansen JA, Creugers NH. Effect of platelet‐rich plasma on bone regeneration in dentistry: a systematic review. Clinical Oral Implants Research 2008;19(6):539‐45. - PubMed
Review Manager 2014 [Computer program]
    1. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rose 2002
    1. Rose FR, Oreffo RO. Bone tissue engineering: hope vs hype. Biochemical and Biophysical Research Communications 2002;292(1):1‐7. [PUBMED: 11890663] - PubMed
Roselló‐Camps 2015
    1. Roselló‐Camps À, Monje A, Lin GH, Khoshkam V, Chávez‐Gatty M, Wang HL, et al. Platelet‐rich plasma for periodontal regeneration in the treatment of intrabony defects: a meta‐analysis on prospective clinical trials. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2015;120(5):562‐74. - PubMed
Vrotsos 1999
    1. Vrotsos JA, Parashis AO, Theofanatos GD, Smulow JB. Prevalence and distribution of bone defects in moderate and advanced adult periodontitis. Journal of Clinical Periodontology 1999;26(1):44‐8. [PUBMED: 9923510] - PubMed
Waerhaug 1979
    1. Waerhaug J. The infrabony pocket and its relationship to trauma from occlusion and subgingival plaque. Journal of Periodontology 1979;50(7):355‐65. [PUBMED: 381633 ] - PubMed

References to other published versions of this review

Del Fabbro 2014
    1. Fabbro M, Panda S, Jayakumar ND, Sankari M, Varghese S, Ramamoorthi S, et al. Autologous platelet concentrates for treatment of periodontal defects. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD011423] - DOI

Publication types

MeSH terms

Substances